“When I first started at CG Oncology, we were building our studies from scratch each time. We had a CTMS, but relied mostly on our CRO to collect information like action items, deviations, and monitoring reports without relying on spreadsheets,” he explains. “But, as our pipeline grew, we realized we …

"Veeva SiteVault has allowed us to get remote monitoring done very quickly and meet our sponsor's strict timelines without any delays."

“Having the right data sources has allowed us to execute in a more timely fashion to identify where the greatest need is for patients.”

"I had to fight the inclination to do regression testing, but the COVID timeline forced me to change. Then I saw how much faster it was without sacrificing quality."

"Eliminating custom programming by using a new technology like Vault EDC spares resources and is a huge time saver for us. And this is on the first study; it's right out of the gate.”

"With modular content, you can guarantee the same consistency across your different channels and deliver content in a valuable way for the customers at the right time."

“We decided from the start that CRM will be the cornerstone of our medical engagement operations. A powerful CRM is crucial for an omnichannel execution with medical affairs.”

"Our goal was to eliminate 90% of manual processes with Vault Study Startup, Vault eTMF, and Vault CTMS. We’re on track to do even better than that."

"Even though we manage the data ourselves, with Vault Safety we can offer customers access to as much of their data as they wish – in real time. This allows them to participate directly in workflows that they want to oversee."

“Vault QMS has been a real game-changer for Heron Therapeutics.”

"Our experience with Veeva Compass has been tremendous. We've been able to leverage a number of insights from the data immediately after getting access to it."

“Hearing that feedback, we turned to Veeva CRM MyInsights. It gave us one place to understand and act on insights — without disrupting their workflow.”

"Our segmentation and targeting initiative yielded major results: 1.5x customer potential, up to double-digit sales uptake, and new customer insights."

"We have started seeing 10 to 13% content reuse, and our proof of concept is now at 69%, which is a great achievement because it impacts the time to market, which we have accelerated by 50%."

“Without clear segmentation and targeting, our efforts were like throwing data blindfolded – pure chance, not strategy, guided by our execution.”